AI English summary of an SEC filing — figures as filed
Eli Lilly said the company's board of directors elected Lucas Montarce, age 47, as executive vice president and chief financial officer on September 9, 2024. The company said the appointment followed an internal and external search across industries.
Key points
AI summaryEli Lilly said the company's board of directors elected Lucas Montarce, age 47, as executive vice president and chief financial officer on September 9, 2024. The company said the appointment followed an internal and external search across industries.
It said Montarce will receive an annual base salary of $1,000,000 and be eligible for an annual target bonus of $1,000,000, effective September 9, 2024.
The company said Montarce has held finance leadership roles since joining Lilly in 2001, served as group vice president, controller and chief financial officer of Lilly Research Laboratories from 2021, and led the Spain, Portugal and Greece hub as president and general manager in 2024.
Eli Lilly said Montarce was appointed effective immediately as a member of the Executive Committee. The company also said there are no arrangements or understandings with any person under which he was selected as an officer, and no family relationship with any director or executive officer.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Lucas Montarce Named Chief Financial Officer
Eli Lilly said the company's board of directors elected Lucas Montarce, age 47, as executive vice president and chief financial officer on September 9, 2024. The company said the appointment followed an internal and external search across industries.
Source · Based on the filing body and exhibits
Annual Base Salary and Target Bonus Terms
It said Montarce will receive an annual base salary of $1,000,000 and be eligible for an annual target bonus of $1,000,000, effective September 9, 2024.
Source · Based on the filing body and exhibits
Finance Leadership Career Since 2001
The company said Montarce has held finance leadership roles since joining Lilly in 2001, served as group vice president, controller and chief financial officer of Lilly Research Laboratories from 2021, and led the Spain, Portugal and Greece hub as president and general manager in 2024.
Source · Based on the filing body and exhibits
Executive Committee Membership and Relationship Disclosure
Eli Lilly said Montarce was appointed effective immediately as a member of the Executive Committee. The company also said there are no arrangements or understandings with any person under which he was selected as an officer, and no family relationship with any director or executive officer.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…